The deal was signed with the Energize programme, a renewable energy purchasing vehicle for pharmeceutical companies.
Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh Toothpaste.
Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...
Haleon said in a prospectus filed earlier this week that it could face "possible liabilities" connected with OTC Zantac, although it is in the midst of indemnity negotiations with GSK and Pfizer ...
The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon ... adults. GSK is trying to bring its vaccine to market ahead of a rival jab from Pfizer, which ...
(Alliance News) - GSK PLC on Monday said the European ... (Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent ...
Energize program sponsors, Haleon and GSK, have collaborated with suppliers participating in the program, Thermo Fisher Scientific and Gilead Sciences, to sign a multi-buyer PPA, with developer X ...
The presentation was sent to our distribution list by email, and you can also find it on gsk.com. Please turn to ... The monetization of Haleon, which generated £2.3 billion and the resolution ...
Shareholders have waited a long time to see all metrics at GSK pointing in the right direction. The divorce from the Haleon consumer ... US competitor Pfizer on the same playing field.